Small-cell lung cancer (SCLC) is one of the most aggressive and deadly types of cancer, often linked to smoking. Although it ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

Although lung cancer screening ... A Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions Mar. 17, 2025 — In the continuing evolution of personalized medicine, a new study has ...

Preliminary results from the AACR 2025 Annual Meeting reveal encouraging clinical responses to the investigational oral agent ...

Overall, rates of new cancer diagnoses and cancer-related deaths have declined, according to the annual cancer statistics ...

As is often the case with younger cancer patients, Margaret had a long journey before getting a lung cancer diagnosis ... their jobs in Oregon and work remotely throughout her treatment in New York.

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

A new report on cancer in the US shows a steady decline in overall deaths from 2001 through 2022. The rate of diagnoses among ...